Toxicokinetics of polybrominated diphenyl ether congeners 47, 99, 100, and 153 in Mice

Toxicological Sciences

Volumn 94, Issue 1, 2006, Pages 28-37

  Staskal, Daniele F ^a,c   Hakk, Heldur ^b   Bauer, Daniel ^a   Diliberto, Janet J ^a   Birnbaum, Linda S ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b U S DEPARTMENT OF AGRICULTURE   (United States)

^c ChemRisk   (United States)

Author keywords

Brominated flame retardant (BFR); Polybrominated diphenyl ether (PBDE); Toxicokinetics

Indexed keywords

2,2',4,4' TETRABROMODIPHENYL ETHER; 2,2',4,4',5 PENTABROMODIPHENYL ETHER; 2,2',4,4',5,5' HEXABROMODIPHENYL ETHER; 2,2',4,4',6 PENTABROMODIPHENYL ETHER; POLYBROMINATED DIPHENYL ETHER; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD; BRAIN TISSUE; CONTROLLED STUDY; EXPOSURE; FECES ANALYSIS; FEMALE; KIDNEY PARENCHYMA; LIVER PARENCHYMA; LUNG PARENCHYMA; METABOLISM; METABOLITE; MOUSE; MUSCLE TISSUE; NONHUMAN; PROTEIN BINDING; SKIN; TISSUE DISTRIBUTION; TISSUE LEVEL; TOXICOKINETICS; URINARY EXCRETION;

ANIMALS; CARBON RADIOISOTOPES; DOSE-RESPONSE RELATIONSHIP, DRUG; FECES; FEMALE; HALOGENATED DIPHENYL ETHERS; INJECTIONS, INTRAVENOUS; MICE; MICE, INBRED C57BL; MOLECULAR STRUCTURE; PHENYL ETHERS; POLYBROMINATED BIPHENYLS; STRUCTURE-ACTIVITY RELATIONSHIP; TIME FACTORS; TISSUE DISTRIBUTION; URINE;

EID: 33749641686     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfl091     Document Type: Article

References (37)

1. Bergman, Å., Klasson-Wehler, E., and Kuroki, H. (1994). Selective retention of hydroxylated PCB metabolites in blood. Environ. Health Perspect. 28, 199-211.
2. Birnbaum, L. S., and Staskal, D. F. (2004). Brominated flame retardants: Cause for concern? Environ. Health Perspect. 112, 9-17.
3. Branchi, I., Alleva, E., and Costa, L. G. (2002). Effects of perinatal exposure to a polybrominated diphenyl ether (PBDE 99) on mouse neurobehavioural development. Neurotoxicology 23, 375-384.
4. BSEF. (2004). What are BFRs? What are they used for? Available at: http://www.bsef-site.com/bromine/what_are_bfrs/. Accessed January 1, 2006.
5. Ceccatelli, R., Faass, O., Schlumpf, M., and Lichtensteiger, W. (2006). Gene expression and estrogen sensitivity in rat uterus after developmental exposure to the polybrominated diphenylether PBDE 99 and PCB. Toxicology 15, 104-116.
6. Chen, L. J., Lebetkin, E. H., Sanders, J. M., and Burka, L. T. (2006). Metabolism and disposition of 2,2′,4,4′,5-pentabromodiphenyl ether (BDE99) following single or repeated administration to rats and mice. Xenobiotica 36, 515-534.
7. Darnerud, P. O., and Risberg, S. (2006). Tissue localisation of tetra- and pentabromodiphenyl ether congeners (BDE-47, -85 and -99) in perinatal and adult C57BL mice. Chemosphere 62, 485-493.
8. Diliberto, J. J., De Vito, M. J., Ross, D. G., and Birnbaum, L. S. (2001). Subchronic exposure of [3H]-2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in female B6C3F1 mice: Relationship of steady-state levels to disposition and metabolism. Toxicol. Sci. 61, 241-255.
9. Eriksson, P., Jakobsson, E., and Fredriksson, A. (2001). Brominated flame retardants: A novel class of developmental neurotoxicants in our environment? Environ. Health Perspect. 109, 903-908.
10. Eriksson, P., Viberg, H., Fischer, M., Wallin, M., and Fredriksson, A. (2002). A comparison on developmental neurotoxic effects of hexabromocyclododecane, 2,2′4,4′,5,5′-hexabromodiphenyl ether. Organohalogen Compd. 57, 389-392.
11. Hakk, H., Larsen, G., and Klasson-Wehler, E. (2002). Tissue disposition, excretion and metabolism of 2,2′,4,4′,5-pentabromodiphenyl ether (BDE-99) in the male Sprague-Dawley rat. Xenobiotica 32, 369-382.
12. Hakk, H., Huwe, J., Low, M., Rutherford, D., and Larsen, G. (2006). Tissue disposition, excretion, and metabolism of 2,2′,4,4′,6-pentabromodiphenyl ether (BDE-100) in male Sprague-Dawley rats. Xenobiotica 36, 79-94.
13. Hale, R. C., La Guardia, M. J., Harvey, E. P., and Mainor, M. (2002). Potential role of fire retardant-treated polyurethane foam as a source of brominated diphenyl ethers to the US environment. Chemosphere 46, 729-735.
14. Hallgren, S., Sinjari, T., Hakansson, H., and Darnerud, P. O. (2001). Effects of polybrominated diphenyl ethers (PBDEs) and polychlorinated biphenyls (PCBs) on thyroid hormone and vitamin A levels in rats and mice. Arch. Toxicol. 75, 200-208.
15. Hites, R. (2004). Polybrominated diphenyl ethers in the environment and people: A meta-analysis of concentrations. Environ. Sci. Technol. 38, 945-956.
16. King, G. F., Dedrick, R. L., Collins, J. M., Matthews, H. D., and Birnbaum, L. S. (1983). Physiological model for the pharmacokinetics of 2,3,7,8-tetrachlorodibenzofuran in several species. Toxicol. Appl. Pharmacol. 67, 390-400.
17. Larsen, G. L., Bakke, J. E., and Huwe, J. K. (1990a). Methylsulphone metabolites of m-dichlorobenzene as ligands for α2μ-globulin in rat kidney and urine. Xenobiotica 20, 7-17.
18. Larsen, G. L., Bergman, Å., and Klasson-Wehler, E. (1990b).Amethylsulphonyl metabolite of a polychlorinated biphenyl can serve as a ligand for α2μ-globulin in rat and major urinary-protein in mice. Xenobiotica 20, 1343-1352.
19. Larsen, G. L., Bergman, Å., Klasson-Wehler, E., and Bass, N. M. (1991). A methylsulfonyl metabolite of a polychlorinated biphenyl can serve as a ligand for liver fatty acid binding protein in rat intestinal mucosa. Chem. Biol. Interact. 77, 315-323.
20. Lilienthal, H., Hack, A., Roth-Harer, A., Grande, S. W., and Talsness, C. E. (2006). Effects of developmental exposure to 2,2,4,4,5-pentabromodiphenyl ether (PBDE-99) on sex steroids, sexual development, and sexually dimorphic behavior in rats. Environ. Health Perspect. 114, 194-201.
21. Lutz, R. J., Dedrick, R. L., Matthews, H. B., Eling, T. E., and Anderson, M. W. (1977). A preliminary pharmacokinetic model fro several chlorinated biphenyls in the rat. Drug Metab. Dispos. 5, 386-396.
22. Mazel, J. V. Jr. (1971). Polyacrylamide gel electrophoresis of viral proteins. Methods Virol. 5, 179-246.
23. Orn, U., and Klasson-Wehler, E. (1998). Metabolism of 2,2′,4,4′-tetrabromodiphenyl ether in rat and mouse. Xenobiotica 28, 199-211.
24. Sanders, J. M., Chen, L. J., Lebetkin, E. H., and Burka, L. T. (2006). Metabolism and disposition of 2,2′,4,4′,-tetrabromodiphenyl ether following administration of single or multiple doses to rats and mice. Xenobiotica 36, 103-117.
25. Staskal, D. F., Diliberto, J. J., De Vito, M. J., and Birnbaum, L. S. (2005). Toxicokinetics of BDE 47 in female mice: Effect of dose, route of exposure, and time. Toxicol. Sci. 83, 215-223.
26. Staskal, D. F., Diliberto, J. J., and Birnbaum, L. S. (2006a). Disposition of BDE 47 in developing mice. Toxicol. Sci. 90, 309-316.
27. Staskal, D. F., Diliberto, J. J., and Birnbaum, L. S. (2006b). Impact of repeated exposure on the toxicokinetics of BDE 47 in mice. Toxicol. Sci. 89, 380-385.
28. Stoker, T. E., Cooper, R. L., Lambright, C. S., Wilson, V. S., Furr, J., and Gray, L. E. (2005). In vivo and in vitro anti-andogenic effects of DE-71, a commercial polybrominated diphenyl ether (PBDE) mixture. Toxicol. Appl. Pharmacol. 207, 78-88.
29. Stoker, T. E., Laws, S. C., Crofton, K. M., Hedge, J. M., Ferrell, J. M., and Cooper, R. L. (2004). Assessment of DE-71, a commercial polybrominated diphenyl ether (PBDE) mixture, in the EDSP male and female pubertal protocols. Toxicol. Sci. 78, 144-155.
30. Talsness, C. E., Shakibaei, M., Kuriyama, S. N., Grande, S. W., Sterner-Kock, A., Schnitker, P., de Souza, C., Grote, K., and Chahoud, I. (2005). Ultrastructural changes observed in rat ovaries following in utero and lactational exposure to low doses of a polybrominated flame retardant. Toxicol. Lett. 157, 189-202.
31. Tuey, D. B., and Matthews, H. B. (1980a). Distribution and excretion of 2,2′,4,4′,5,5′-hexachlorobiphenyl in rats and man: Pharmacokinetic model predictions. Toxicol. Appl. Pharmacol. 53, 420-431.
32. Tuey, D. B., and Matthews, H. B. (1980b). Use of a physiologic compartmental model for the rat to describe the pharmacokinetics of several chlorinated biphenyls in the mouse. Drug Metab. Dispos. 8, 397-403.
33. Viberg, H., Fredriksson, A., and Eriksson, P. (2002). Neonatal exposure to the brominated flame retardant 2,2′,4,4′,5-pentabromodiphenyl ether causes altered susceptibility in the cholinergic transmitter system in the adult mouse. Toxicol. Sci. 67, 104-107.
34. Viberg, H., Fredriksson, A., Jakobsson, E., Orn, U., and Eriksson, P. (2003). Neurobehavioral derangements in adult mice receiving decabrominated diphenyl ether (PBDE 209) during a defined period of neonatal brain development. Toxicol. Sci. 76, 112-120.
35. Viberg, H., Fredriksson, A., and Eriksson, P. (2004a). Investigations of strain and/or gender difference in developmental neurotoxic effects of polybrominated diphenyl ethers in mice. Toxicol. Sci. 81, 344-353.
36. Viberg, H., Fredriksson, A., and Eriksson, P. (2004b). Neonatal exposure to polybrominated diphenyl ether (PBDE 153) disrupts behavior, impairs learning and memory, and decreases hippocampal cholinergic receptors in adult mice. Toxicol. Appl. Pharmacol. 192, 95-106.
37. Zhou, T., Taylor, M. M., De Vito, M. J., and Crofton, K. M. (2002). Developmental exposure to brominated diphenyl sethers results in thyroid hormone disruption. Toxicol. Sci. 66, 105-116.